These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

501 related items for PubMed ID: 19648904

  • 1. Long-term efficacy of botulinum toxin A for treatment of blepharospasm, hemifacial spasm, and spastic entropion: a multicentre study using two drug-dose escalation indexes.
    Cillino S, Raimondi G, Guépratte N, Damiani S, Cillino M, Di Pace F, Casuccio A.
    Eye (Lond); 2010 Apr; 24(4):600-7. PubMed ID: 19648904
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Botulinum toxin treatment of hemifacial spasm and blepharospasm: objective response evaluation.
    Thussu A, Barman CR, Prabhakar S.
    Neurol India; 1999 Sep; 47(3):206-9. PubMed ID: 10514580
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Safety, effectiveness, and duration of effect of BOTOX after switching from Dysport for blepharospasm, cervical dystonia, and hemifacial spasm dystonia, and hemifacial spasm.
    Bihari K.
    Curr Med Res Opin; 2005 Mar; 21(3):433-8. PubMed ID: 15811212
    [Abstract] [Full Text] [Related]

  • 7. Riolan's muscle: action and indications for botulinum toxin injection.
    Mackie IA.
    Eye (Lond); 2000 Jun; 14 ( Pt 3A)():347-52. PubMed ID: 11026998
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Prospective, randomized, double-blind study, comparing botulinum toxins type a botox and prosigne for blepharospasm and hemifacial spasm treatment.
    Quagliato EM, Carelli EF, Viana MA.
    Clin Neuropharmacol; 2010 Jun; 33(1):27-31. PubMed ID: 20124784
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hemifacial spasm: results of treatment with low dose botulinum toxin injection.
    Suputtitada A, Phanthumchinda K, Locharernkul C, Suwanwela NC.
    J Med Assoc Thai; 2004 Oct; 87(10):1205-11. PubMed ID: 15560699
    [Abstract] [Full Text] [Related]

  • 19. Dysport (botulinum toxin type A) in routine therapeutic usage: a telephone needs assessment survey of European physicians to evaluate current awareness and adherence to product labeling changes.
    Hubble J, Schwab J, Hubert C, Abbott CC.
    Clin Neuropharmacol; 2013 Oct; 36(4):122-7. PubMed ID: 23783005
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.